With all these opinions here and the recent PP............has me thinking this stock is undervalued severely. The stock price range was 23 cents to 29 cents but did not collapse back to 22 or 23 cents on the last decline. The stock price stopped at 27 cents, which could now be the floor for the stock price. If this analyst is correct this stock should be around 35 cents to 40 cents. Something tells me there is a huge amount of suppport to surpress the stock price but once that has abated this could pop to $1 buck very fast, especially if we get those 2 designations. Furthermore with those designations BIG Pharma will be sniffing around for a buyout or JV partnership.